SCHEMBL12014892

SCHEMBL12014892

c1ccc2c(c1)c1ccccc1n2-c1nc(-n2c3ccccc3c3ccccc32)c2nc(-n3c4ccccc4c4ccccc43)nc(-n3c4ccccc4c4ccccc43)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ATM Q13315 2/20 0.43
▸ GPR3 P46089 1/20 0.37
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ POLB P06746 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ MAPT P10636 4/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TSHR P16473 3/20 0.32
▸ CASP1 P29466 2/20 0.32
▸ CASP7 P55210 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12014895 0.88 KDM4E (0.35) L3MBTL1KDM4EATMALDH1A1MAPT
SCHEMBL23177382 0.84 KDM4E (0.43) L3MBTL1KDM4EATMGPR3CYP1A2
SCHEMBL1303181 0.83 KDM4E (0.54) L3MBTL1KDM4EATMGPR3CYP1A2
SCHEMBL29389255 0.83 KDM4E (0.54) L3MBTL1KDM4EATMGPR3CYP1A2
SCHEMBL12014910 0.81 KDM4E (0.35) L3MBTL1KDM4EATMCYP1A2CYP2C19
SCHEMBL12014833 0.81 HPGD (0.47) L3MBTL1KDM4EATMPOLBALDH1A1
SCHEMBL23373431 0.80 GPR3 (0.44) L3MBTL1KDM4EGPR3ALDH1A1NPC1
SCHEMBL16905736 0.80 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1NPC1
SCHEMBL16905906 0.79 ALDH1A1 (0.46) KDM4EALDH1A1MAPTHSD17B10TP53
SCHEMBL16905909 0.79 HRH4 (0.43) L3MBTL1KDM4EATMGPR3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120217485-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2012-08-30 — — US disclosed
US-20120217485-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2012-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120217485-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME OCIAD2, OCIAD1, OSBPL8 L3MBTL1 528/4885KDM4E 1835/4885ATM 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback